BioFocus DPI has today released an enhanced version of its StarDrop software for guiding decisions in drug discovery. StarDrop 4.2 allows users to directly access data from multiple sources and to interface with other industry standard informatics platforms such as Pipeline Pilot®. By placing StarDrop at the centre of the drug discovery process and applying its unique approach for identifying high quality chemistry, users can maximize the likelihood of success.

Commenting on the product, Dr. Matt Segall, Senior Director ADMET of BioFocus DPI, said: “This latest development of the platform follows feedback from our rapidly growing customer base. StarDrop 4.2 will provide more flexibility to share and apply information in drug discovery.”

StarDrop 4.2 will make its debut at MipTec (Booth 427) in Basel, Switzerland from 14-16 October, where Matt Segall will be speaking on ‘Multiparameter Optimisation: Achieving Balance with Confidence’. It can also be seen at AAPS Annual Meeting (Booth 225) in Atlanta GA from 16-20 November.

For more information about StarDrop visit www.biofocusdpi.com

About BioFocus DPI

BioFocus DPI aims to expand its partners’ drug pipelines by accelerating the gene-tocandidate discovery process. This is achieved through a comprehensive discovery platform, which includes target discovery in human primary cells, focused as well as diverse compound libraries, in vitro and cell-based screening, structural biology, medicinal chemistry and ADME/PK services, supported by unique chemogenomic and informatics tools. As the service division of Galapagos, BioFocus DPI has over 300 employees in four countries worldwide.

BioFocus® and StarDrop™ are trademarks of Galapagos NV and/or its affiliates. Pipeline Pilot® is a trademark of Accelrys Software Inc.